logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Namsa Acquires Uk-Based Perfectus Biomed Group To Enhance Customized Microbiological Solutions

Oct 04, 2022•about 3 years ago

Acquiring Company

NAMSA

Acquired Company

Perfectus Biomed Group

Medical DeviceBiotechnologyHealth CareManufacturing

Description

NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of Perfectus Biomed Group, a UK-based laboratory providing customized microbiological services.

Company Information

Company

NAMSA

About

NAMSA is a world-leading MedTech testing, clinical, and regulatory consulting firm dedicated to accelerating medical device product development. With a deep pool of testing, clinical, and regulatory experts, NAMSA helps medical device sponsors improve healthcare and is committed to enhancing stakeholder value through strategic outsourcing and comprehensive in-house services.

Related People

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed